BlogZone Get the app
News Commentary

Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

NPR News 7 Aug 2026 1 views

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

(Image credit: Fred Tanneau)

BlogZone shows headlines and summaries from public news feeds. The full story is published by NPR News.

Read the full story at NPR News →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in News Commentary

News Commentary

US has lost measles elimination status, global health authorities say

The U.S. has lost its status as a country where measles is eliminated, according to researchers with direct knowledge of the deliberations at the Pan American Health Organization.

NPR News · 40 min ago
News Commentary

'Can you believe it?': SpaceX catches part of its Starship rocket on return to Earth

SpaceX has performed the historic catch using mechanical arms nicknamed "chopsticks".

BBC World · 46 min ago
News Commentary

Ronaldo-less Portugal thrashed 4-1 by Denmark in the Nations League

Rasmus Hojlund stars with brace on as Denmark close in on a spot in the Nations League quarterfinals.

Al Jazeera · 55 min ago